当前关于结核病免疫接种的知识。
Present knowledge of immunization against tuberculosis.
作者信息
Dam H G, Toman K, Hitze K L, Guld J
出版信息
Bull World Health Organ. 1976;54(3):255-69.
Abstract
This is a selective review, which, after recalling some immunological aspects, analyses the present knowledge on the protective efficacy of BCG vaccination, the vaccination reactions and complications that may be observed, and current methods of vaccine production and control. As regards the application of BCG vaccination, particular attention is given to dosage and vaccination techniques, direct and simultaneous vaccination, and revaccination. Finally, the evaluation of BCG vaccination programmes is briefly discussed.
摘要
这是一篇选择性综述，在回顾了一些免疫学方面的内容后，分析了关于卡介苗接种的保护效果、可能观察到的接种反应和并发症以及当前疫苗生产和控制方法的现有知识。关于卡介苗接种的应用，特别关注剂量和接种技术、直接接种和同时接种以及复种。最后，简要讨论了卡介苗接种计划的评估。
相似文献
1
Present knowledge of immunization against tuberculosis.当前关于结核病免疫接种的知识。
Bull World Health Organ. 1976;54(3):255-69.
2
[Where do we stand with BCG vaccination programme in Japan?].日本卡介苗接种计划的现状如何？
Kekkaku. 2001 Apr;76(4):385-97.
3
The success and failure of BCG - implications for a novel tuberculosis vaccine.卡介苗的成败——对新型结核病疫苗的启示
Nat Rev Microbiol. 2005 Aug;3(8):656-62. doi: 10.1038/nrmicro1211.
4
An American view of BCG vaccination, illustrated by results of a controlled trial in Puerto Rico.以波多黎各一项对照试验结果为例的美国对卡介苗接种的看法。
Scand J Respir Dis. 1972;53(4):207-17.
5
[Vaccine prophylaxis of tuberculosis: implication and problems].[结核病的疫苗预防：意义与问题]
Probl Tuberk Bolezn Legk. 2009(1):10-6.
6
[Novel vaccines against M. tuberculosis].[新型抗结核分枝杆菌疫苗]
Kekkaku. 2006 Dec;81(12):745-51.
7
[The use of factorial correlation-regression analysis in the evaluation of the efficiency of BCG immunization in children].[析因相关回归分析在评估儿童卡介苗免疫效果中的应用]
Probl Tuberk Bolezn Legk. 2006(3):35-7.
8
[Results of the BCG vaccination in Hungary since 1929: evaluation of preventive and immunotherapeutic effectiveness].[1929年以来匈牙利卡介苗接种的结果：预防和免疫治疗效果评估]
Orv Hetil. 1998 Jun 28;139(26):1563-70.
9
Direct BCG vaccination--simultaneous BCG and smallpox vaccination.直接卡介苗接种——卡介苗与天花疫苗同时接种。
Bull Int Union Tuberc. 1968 Dec;41:53-9.
10
Research on BCG vaccination.卡介苗接种研究。
Adv Tuberc Res. 1984;21:79-106.
引用本文的文献
1
Past, Present and Future of Bacillus Calmette-Guérin Vaccine Use in China.卡介苗在中国应用的过去、现在与未来
Vaccines (Basel). 2022 Jul 20;10(7):1157. doi: 10.3390/vaccines10071157.
2
Immunogenicity and safety of early vs delayed BCG vaccination in moderately preterm (31-33 weeks) infants.中度早产（31 - 33周）婴儿早期与延迟接种卡介苗的免疫原性和安全性
Hum Vaccin Immunother. 2015;11(12):2864-71. doi: 10.1080/21645515.2015.1074361.
3
Does BCG vaccine prevent tuberculous meningitis?卡介苗能预防结核性脑膜炎吗？
Arch Dis Child. 1996 Feb;74(2):144-7. doi: 10.1136/adc.74.2.144.
4
BCG in Britain.英国的卡介苗
Br Med J. 1980 Sep 27;281(6244):825.
5
BCG-induced changes in size of thymic cortex and thymus-dependent areas in spleen and lymph nodes of mice.卡介苗诱导的小鼠胸腺皮质以及脾脏和淋巴结中胸腺依赖区大小的变化。
Clin Exp Immunol. 1980 Jan;39(1):60-5.
6
[Vaccination: 1982 status].[疫苗接种：1982年状况]
Soz Praventivmed. 1982 Sep;27(4):197-204. doi: 10.1007/BF02095321.
7
A case-control study to evaluate the effectiveness of mass neonatal BCG vaccination among Canadian Indians.一项评估加拿大印第安人群体新生儿卡介苗大规模接种效果的病例对照研究。
Am J Public Health. 1986 Jul;76(7):783-6. doi: 10.2105/ajph.76.7.783.
8
In vitro characterization of T cells from Mycobacterium w-vaccinated mice.来自接种卡介苗小鼠的T细胞的体外特性分析
Infect Immun. 1992 Jan;60(1):257-63. doi: 10.1128/iai.60.1.257-263.1992.
9
Comment on "tuberculosis studies in Muscogee County, Georgia".关于《佐治亚州马斯考吉县的结核病研究》的评论
Public Health Rep. 1977 May-Jun;92(3):285-6.
10
High-viability lyophilized Bacille Calmette-Guérin vaccine produced by deep-culture technique.采用深层培养技术生产的高活性冻干卡介苗。
Appl Environ Microbiol. 1977 Nov;34(5):495-9. doi: 10.1128/aem.34.5.495-499.1977.
本文引用的文献
1
Variation in the duration of tuberculin skin sensitivity produced by two strains of BCG.两株卡介苗产生的结核菌素皮肤敏感性持续时间的差异。
Am Rev Tuberc. 1949 Nov;60(5):541-6. doi: 10.1164/art.1949.60.5.541.
2
Variability of BCG strains (Bacillus Calmette-Guérin).卡介苗菌株（卡尔梅特-介朗杆菌）的变异性
J Exp Med. 1951 Jun;93(6):559-72. doi: 10.1084/jem.93.6.559.
3
ACQUIRED IMMUNITY TO TUBERCULOSIS.
Am Rev Respir Dis. 1965 Jun;91:939. doi: 10.1164/arrd.1965.91.6.939.
4
TUBERCULOSIS IN HONG KONG.
Tubercle. 1963 Sep;44:334-45. doi: 10.1016/s0041-3879(63)80101-4.
5
The heterogeneity of BCG.卡介苗的异质性
Am Rev Respir Dis. 1961 Aug;84:288-90. doi: 10.1164/arrd.1961.84.2.288.
6
Differential characteristics in vitro and in vivo of several substrains of BCG. IV. Immunizing effectiveness.卡介苗几个亚株的体内外差异特性。IV. 免疫效力。
Am Rev Tuberc. 1956 Nov;74(5):699-717. doi: 10.1164/artpd.1956.74.5.699.
7
The occurrence of pulmonary lesions in BCG-vaccinated and unvaccinated persons.接种卡介苗者和未接种卡介苗者肺部病变的发生情况。
Am Rev Tuberc. 1953 Nov;68(5):695-712. doi: 10.1164/art.1953.68.5.695.
8
Long-term results of BCG vaccination in the southern United States.美国南部卡介苗接种的长期结果。
Am Rev Respir Dis. 1966 Feb;93(2):171-83. doi: 10.1164/arrd.1966.93.2.171.
9
Identifying the tuberculous infected. The dual-test technique.识别结核感染。双重检测技术。
JAMA. 1968 Jul 15;205(3):167-9.
10
Comparison of the efficacy of liquid and freeze-dried strains of B.C.G. vaccine in preventing tuberculosis.卡介苗液体菌株和冻干菌株预防结核病效果的比较。
Br Med J. 1970 Oct 17;4(5728):148-50. doi: 10.1136/bmj.4.5728.148.
Zotero 插件